Immediate Impact

1 by Nobel laureates 1 from Science/Nature 57 standout
Sub-graph 1 of 25

Citing Papers

Mitochondria-Targeting Type-I Photodrug: Harnessing Caspase-3 Activity for Pyroptotic Oncotherapy
2024 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
2 intermediate papers

Works of D. Gibson being referenced

Phase I clinical and pharmacologic study of the focal adhesion kinase (FAK) inhibitor GSK2256098 in pts with advanced solid tumors.
2012
610 Loss of the Tumor Suppressor Merlin as a Potential Predictive Biomarker of Clinical Activity for the Oral, Focal Adhesion Kinase (FAK) Inhibitor GSK2256098 in Pts with Recurrent Mesothelioma
2012

Author Peers

Author Last Decade Papers Cites
D. Gibson 228 244 206 9 436
S. Savage 291 256 257 8 484
Teresa M. Hopper 223 195 238 6 467
James A. Onori 226 211 248 4 478
Amogh Boloor 211 185 242 5 482
Stephen Brincat 227 233 193 9 469
Anita S. Jorna 95 174 218 9 482
T. Christopher Windham 110 178 203 14 435
Herb Kotz 131 320 150 23 486
Ninad Dewal 193 190 219 9 489
Christa G.M. Gadellaa-van Hooijdonk 117 340 104 7 491

All Works

Loading papers...

Rankless by CCL
2026